308 related articles for article (PubMed ID: 23137845)
1. Systemic immunization with an epitope-based vaccine elicits a Th1-biased response and provides protection against Helicobacter pylori in mice.
Li HB; Zhang JY; He YF; Chen L; Li B; Liu KY; Yang WC; Zhao Z; Zou QM; Wu C
Vaccine; 2012 Dec; 31(1):120-6. PubMed ID: 23137845
[TBL] [Abstract][Full Text] [Related]
2. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
[TBL] [Abstract][Full Text] [Related]
3. Antibody Production and Th1-biased Response Induced by an Epitope Vaccine Composed of Cholera Toxin B Unit and Helicobacter pylori Lpp20 Epitopes.
Li Y; Chen Z; Ye J; Ning L; Luo J; Zhang L; Jiang Y; Xi Y; Ning Y
Helicobacter; 2016 Jun; 21(3):234-48. PubMed ID: 26332255
[TBL] [Abstract][Full Text] [Related]
4. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB.
Yang J; Dai LX; Pan X; Wang H; Li B; Zhu J; Li MY; Shi XL; Wang BN
Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25846576
[TBL] [Abstract][Full Text] [Related]
5. Immunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB/c mice.
Li B; Chen L; Sun H; Yang W; Hu J; He Y; Wei S; Zhao Z; Zhang J; Li H; Zou Q; Wu C
Sci Rep; 2015 Oct; 5():14793. PubMed ID: 26434384
[TBL] [Abstract][Full Text] [Related]
6. Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB/c mice model.
Guo L; Liu K; Zhao W; Li X; Li T; Tang F; Zhang R; Wu W; Xi T
Appl Microbiol Biotechnol; 2013 Mar; 97(6):2367-78. PubMed ID: 23064457
[TBL] [Abstract][Full Text] [Related]
7. [The role of local immune response in gastric mucosa in the protection induced by Helicobacter pylori vaccine with chitosan as adjuvant].
Xie Y; Gong YF; Zhou NJ; Chen J; Zhou XJ; Lü NH; Wang CW
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(37):2629-35. PubMed ID: 16321324
[TBL] [Abstract][Full Text] [Related]
8. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
Li X; Xing Y; Guo L; Lv X; Song H; Xi T
Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
[TBL] [Abstract][Full Text] [Related]
9. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses.
Nyström J; Svennerholm AM
Vaccine; 2007 Mar; 25(14):2591-8. PubMed ID: 17239498
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB/c mice model.
Guo L; Liu K; Xu G; Li X; Tu J; Tang F; Xing Y; Xi T
Appl Microbiol Biotechnol; 2012 Sep; 95(6):1437-44. PubMed ID: 22569640
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Protection Against
Guo L; Hong D; Wang S; Zhang F; Tang F; Wu T; Chu Y; Liu H; He M; Yang H; Yin R; Liu K
Front Immunol; 2019; 10():1185. PubMed ID: 31191547
[TBL] [Abstract][Full Text] [Related]
12. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization.
Akhiani AA; Stensson A; Schön K; Lycke N
Scand J Immunol; 2006 Feb; 63(2):97-105. PubMed ID: 16476008
[TBL] [Abstract][Full Text] [Related]
13. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
Xing Y; Liu W; Li X; Guo L; Lv X; Xi T
Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472
[TBL] [Abstract][Full Text] [Related]
15. Intranasal immunization with immunodominant epitope peptides derived from HpaA conjugated with CpG adjuvant protected mice against Helicobacter pylori infection.
Yang WC; Sun HW; Sun HQ; Yuan HM; Li B; Li HB; Hu J; Yang Y; Zou QM; Guo H; Wu C; Chen L
Vaccine; 2018 Oct; 36(42):6301-6306. PubMed ID: 30217524
[TBL] [Abstract][Full Text] [Related]
16. Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB/c mice model.
Guo L; Yin R; Liu K; Lv X; Li Y; Duan X; Chu Y; Xi T; Xing Y
Appl Microbiol Biotechnol; 2014 Apr; 98(8):3495-507. PubMed ID: 24370888
[TBL] [Abstract][Full Text] [Related]
17. Immunological features and the ability of inhibitory effects on enzymatic activity of an epitope vaccine composed of cholera toxin B subunit and B cell epitope from Helicobacter pylori urease A subunit.
Guo L; Li X; Tang F; He Y; Xing Y; Deng X; Xi T
Appl Microbiol Biotechnol; 2012 Mar; 93(5):1937-45. PubMed ID: 22134639
[TBL] [Abstract][Full Text] [Related]
18. The C-terminally encoded, MHC class II-restricted T cell antigenicity of the Helicobacter pylori virulence factor CagA promotes gastric preneoplasia.
Arnold IC; Hitzler I; Engler D; Oertli M; Agger EM; Müller A
J Immunol; 2011 Jun; 186(11):6165-72. PubMed ID: 21518972
[TBL] [Abstract][Full Text] [Related]
19. Intranasal immunization with an epitope-based vaccine results in earlier protection, but not better protective efficacy, against Helicobacter pylori compared to subcutaneous immunization.
Li H; Zhang J; He Y; Li B; Chen L; Huang W; Zou Q; Wu C
Immunol Res; 2015 Jul; 62(3):368-76. PubMed ID: 26044541
[TBL] [Abstract][Full Text] [Related]
20. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection.
Shi T; Liu WZ; Gao F; Shi GY; Xiao SD
Helicobacter; 2005 Feb; 10(1):71-9. PubMed ID: 15691317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
